Oruka Therapeutics, Inc.
public_traded
Oruka Therapeutics, Inc. is publicly traded on NASDAQ under ticker ORKA.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.